The popular GLP-1 receptor agonists, originally approved for T2D, may also be beneficial for patients with T1D—at least, that’s what findings from a small study published in NEJM imply.
A new report from CDC finds that in recent years, the number of people who overdosed and died from counterfeit prescription drugs has more than doubled. From mid-2019 to the end of 2021, overdose deaths involving counterfeit drugs increased from 2% to 4.7%.
Findings from a recent study published in JAMA Network Open suggest that postnatal SSRI treatment may bring benefits in the long term to not only mothers, but also their offspring.
According to a new recommendation statement published in JAMA, the U.S. Preventive Services Task Force (USPSTF) recommends PrEP for those at high risk of contracting HIV to comprise newer antiretroviral drugs, including a long-acting option.
The prolonged use of PPI drugs, which are designed to control acid reflux and other gastrointestinal disorders, may raise the risk of dementia, according to a new study in Neurology.